Gene · 1633
Papers2,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Efficacy of Third-Generation Percutaneous Vertebral Augmentation System (PVAS) in Osteoporotic Vertebral Compression Fractures (OVCFs): A Systematic Review and Meta-analysis. | Biomed Res Int | 2022 | 35578725 | PubTator, text mining | PubMed |
| Skeletal Torsion Tunneling and Methyl Internal Rotation: The Coupled Large Amplitude Motions in Phenyl Acetate. | Molecules | 2022 | 35566082 | PubTator, text mining | PubMed |
| The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment. | Cells | 2022 | 35563739 | PubTator, text mining | PubMed |
| Does Intracellular Metabolism Render Gemcitabine Uptake Undetectable in Mass Spectrometry? | Int J Mol Sci | 2022 | 35563081 | PubTator, text mining | PubMed |
| Novel insights into the biomarkers and therapies for primary central nervous system lymphoma. | Ther Adv Med Oncol | 2022 | 35558005 | PubTator, text mining | PubMed |
| Pancreatic INS-1 β-Cell Response to Thapsigargin and Rotenone: A Comparative Proteomics Analysis Uncovers Key Pathways of β-Cell Dysfunction. | Chem Res Toxicol | 2022 | 35544339 | PubTator, text mining | PubMed |
| Correlation between myoferlin expression and lymph node metastasis in papillary thyroid carcinoma. | J Pathol Transl Med | 2022 | 35535365 | PubTator, text mining | PubMed |
| Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment. | J Nanobiotechnology | 2022 | 35501802 | PubTator, text mining | PubMed |
| Exosomes and ferroptosis: roles in tumour regulation and new cancer therapies. | PeerJ | 2022 | 35497192 | PubTator, text mining | PubMed |
| Roles of Embryonic Lethal Abnormal Vision-Like RNA Binding Proteins in Cancer and Beyond. | Front Cell Dev Biol | 2022 | 35465324 | PubTator, text mining | PubMed |
| Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia. | Pharmaceutics | 2022 | 35456712 | PubTator, text mining | PubMed |
| Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety. | Wien Med Wochenschr | 2022 | 35451662 | PubTator, text mining | PubMed |
| Ki67 Index Is the Most Powerful Factor for Predicting the Recurrence in Atypical Meningioma : Retrospective Analysis of 99 Patients in Two Institutes. | J Korean Neurosurg Soc | 2022 | 35418005 | PubTator, text mining | PubMed |
| Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment? | Int J Mol Sci | 2022 | 35408980 | PubTator, text mining | PubMed |
| Gemcitabine Cooperates with Everolimus to Inhibit the Growth of and Sensitize Malignant Meningioma Cells to Apoptosis Induced by Navitoclax, an Inhibitor of Anti-Apoptotic BCL-2 Family Proteins. | Cancers (Basel) | 2022 | 35406478 | PubTator, text mining | PubMed |
| Oral Cladribine in Patients who Change From First-Line Disease Modifying Treatments for Multiple Sclerosis: Protocol of a Prospective Effectiveness and Safety Study (CLAD CROSS). | J Cent Nerv Syst Dis | 2022 | 35392050 | PubTator, text mining | PubMed |
| RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer. | Semin Cancer Biol | 2022 | 35381329 | PubTator, text mining | PubMed |
| Entecavir competitively inhibits deoxyguanosine and deoxyadenosine phosphorylation in isolated mitochondria and the perfused rat heart. | J Biol Chem | 2022 | 35358513 | PubTator, text mining | PubMed |
| Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile. | J Clin Oncol | 2022 | 35357885 | PubTator, text mining | PubMed |
| Ponesimod in the Treatment of Relapsing Forms of Multiple Sclerosis: An Update on the Emerging Clinical Data. | Degener Neurol Neuromuscul Dis | 2022 | 35356493 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1633/papers?page=18